Giardiasis
📧 Sign up to get email alerts when something new happens for Giardiasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-12-15FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)
FDA approved a supplemental application for TINDAMAX (tinidazole) from Mission Pharmacal Company.
-
FDA approval · 2021-10-14FDA Approved: METRONIDAZOLE — Original Application (Solaris Pharma Corporation)
FDA approved Solaris Pharma Corporation's generic metronidazole (METRONIDAZOLE) under an original ANDA.
-
FDA approval · 2021-09-03FDA Approved: METRONIDAZOLE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for Metronidazole, enabling a generic version of the antibiotic/antiprotozoal.
-
FDA approval · 2021-08-19FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for METRONIDAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., signaling an approved change…
-
FDA approval · 2021-08-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Metronidazole from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-05FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole submitted by Baxter Healthcare Corporation.
-
FDA approval · 2020-11-27FDA Approved: NITAZOXANIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves the Original Application for a generic nitazoxanide product by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Treatment of Giardia Lamblia Infections in Children [Phase 4]
Phase 4 clinical trial update on treatment of Giardia lamblia infections in children has been terminated; results posted.
-
FDA approval · 2020-08-03FDA Approved: METRONIDAZOLE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic metronidazole (ANDA 212435), enabling a generic version of metronidazole for its establi…
-
FDA approval · 2020-05-26FDA Approved: TINDAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for tinidazole from Rising Pharma Holdings, Inc.
-
FDA approval · 2019-08-14FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Metronidazole from Unichem Pharmaceuticals (USA), Inc., supporting a generic version under A…
-
FDA approval · 2019-07-29FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Metronidazole from Aurobindo Pharma Limited, updating an existing generic product approval.
-
FDA label_change · 2019-06-07FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)
FDA approved a supplemental application for TINDAMAX (tinidazole) to update the labeling, including expansion of indications.
-
FDA approval · 2019-02-25FDA Approved: METRONIDAZOLE — Original Application (Hospira, Inc.)
FDA approves Hospira's original application for metronidazole (generic) for use in several anaerobic bacterial infections and protozoal infe…
-
FDA approval · 2018-04-03FDA Approved: FLAGYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Flagyl (metronidazole) from Pfizer Laboratories Div Pfizer Inc, resulting in changes to the …
-
FDA approval · 2017-12-12FDA Approved: METRONIDAZOLE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals' generic metronidazole under an Original Application (ANDA209794).
-
FDA approval · 2017-12-04FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole from Baxter Healthcare Corporation, typically reflecting labeling updates or o…
-
FDA approval · 2017-09-05FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for METRONIDAZOLE from Aurobindo Pharma Limited (ANDA 203974).
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Parasitic Infections of the Gastrointestinal Tract
Clinical trial update from the National Institute of Allergy and Infectious Diseases notes a terminated study on parasitic infections of the…
-
FDA approval · 2016-11-16FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
FDA approved Metronidazole via an original application from Viona Pharmaceuticals Inc (ANDA206560). The approval confirms its use for anaero…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
This completed clinical trial update reports on diagnosing a range of neglected tropical diseases in patients with persistent digestive diso…
-
FDA approval · 2016-04-01FDA Approved: TINDAMAX — Supplemental Application (Mission Pharmacal Company)
The FDA approved a supplemental application for TINDAMAX (tinidazole) from Mission Pharmacal Company, resulting in an updated labeling for t…
-
FDA approval · 2015-08-04FDA Approved: TINIDAZOLE — Original Application (Edenbridge Pharmaceuticals LLC.)
FDA approves Edenbridge Pharmaceuticals LLC's original ANDA for tinidazole (generic tinidazole), authorizing a generic version of the antibi…
-
FDA approval · 2015-05-29FDA Approved: METRONIDAZOLE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Metronidazole, granting approval for a generic metronidazole product. This …
-
FDA approval · 2013-10-09FDA Approved: TINDAZOLE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic tinidazole product under Rising Pharma Holdings' original ANDA, enabling broader access to tinidazole for protozoal i…